HAEMONETICS CORP cotiza a 121.72 USD y tiene una capitalización bursátil de $5.5B. En los últimos 12 meses ha facturado $1.4B con un margen de flujo de caja libre del 19.5%. Cotiza a 19.0 veces su flujo de caja libre (P/FCF) y a un PER de 57.5. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments. It provides automated plasma collection systems, donor management software, and supporting software solutions, such as NexSys PCS plasmaph…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $1.14 | $1.29 | $1.31 |
| Estimado | $1.29 | $1.08 | $1.27 | $1.25 |
| Sorpresa | — | +5.6% | +1.6% | +4.8% |
| Métrica | HAE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 59.0% | 57.0% | +2.0% |
| Operating Margin | 11.8% | -38.6% | +50.4% |
| Net Margin | 7.3% | -33.6% | +40.9% |
| FCF Margin | 19.5% | -13.9% | +33.4% |
| ROE | 12.2% | -40.4% | +52.6% |
| ROA | 4.1% | -32.0% | +36.1% |
| Current Ratio | 2.95 | 2.84 | +0.11 |
| Debt / Equity | 1.56 | 0.28 | +1.28 |